Citigroup
ZLAB icon

Citigroup’s Zai Lab ZLAB Stock Holding History

Citigroup’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18K Sell
959
-4,192
-81% -$77.7K ﹤0.01% 4862
2025
Q4 		$90.9K Sell
5,151
-3,115
-38% -$72.9K ﹤0.01% 4359
2025
Q3 		$280K Sell
8,266
-246
-3% -$8.47K ﹤0.01% 3854
2025
Q2 		$298K Buy
8,512
+1,393
+20% +$45.8K ﹤0.01% 3882
2025
Q1 		$257K Sell
7,119
-63,835
-90% -$1.96M ﹤0.01% 4055
2024
Q4 		$1.86M Buy
70,954
+1,207
+2% +$33.5K ﹤0.01% 2881
2024
Q3 		$1.68M Sell
69,747
-35,256
-34% -$666K ﹤0.01% 2811
2024
Q2 		$1.82M Buy
105,003
+103,244
+5,869% +$1.82M ﹤0.01% 2426
2024
Q1 		$28.2K Sell
1,759
-921
-34% -$19.4K ﹤0.01% 4917
2023
Q4 		$73.2K Sell
2,680
-122,808
-98% -$3.24M ﹤0.01% 4334
2023
Q3 		$3.05M Sell
125,488
-230
-0.2% -$6.13K ﹤0.01% 1715
2023
Q2 		$3.49M Sell
125,718
-386,852
-75% -$12.7M ﹤0.01% 1743
2023
Q1 		$17M Buy
512,570
+446,515
+676% +$17.1M 0.01% 897
2022
Q4 		$2.03M Sell
66,055
-43,946
-40% -$1.39M ﹤0.01% 2028
2022
Q3 		$3.76M Sell
110,001
-14,364
-12% -$615K ﹤0.01% 1709
2022
Q2 		$4.31M Buy
124,365
+148
+0.1% +$5.22K ﹤0.01% 1615
2022
Q1 		$5.46M Buy
124,217
+87,400
+237% +$4.23M ﹤0.01% 1615
2021
Q4 		$2.31M Sell
36,817
-1,439
-4% -$122K ﹤0.01% 2503
2021
Q3 		$4.03M Sell
38,256
-9,086
-19% -$1.3M ﹤0.01% 1962
2021
Q2 		$8.38M Sell
47,342
-10,953
-19% -$1.76M 0.01% 1538
2021
Q1 		$7.78M Buy
58,295
+2,266
+4% +$351K 0.01% 1514
2020
Q4 		$7.58M Buy
56,029
+9,912
+21% +$1.01M ﹤0.01% 1787
2020
Q3 		$3.84M Buy
46,117
+3,913
+9% +$314K ﹤0.01% 2088
2020
Q2 		$3.47M Buy
42,204
+4,973
+13% +$336K ﹤0.01% 2216
2020
Q1 		$1.92M Buy
37,231
+30,927
+491% +$1.61M ﹤0.01% 2523
2019
Q4 		$262K Buy
6,304
+3,890
+161% +$144K ﹤0.01% 4952
2019
Q3 		$78K Buy
2,414
+191
+9% +$6.55K ﹤0.01% 5846
2019
Q2 		$77K Buy
2,223
+864
+64% +$25.4K ﹤0.01% 6106
2019
Q1 		$40K Buy
+1,359
New +$37.2K ﹤0.01% 6521
2018
Q4 		– Sell
-25,383
Closed -$494K – 7856
2018
Q3 		$494K Buy
+25,383
New +$550K ﹤0.01% 4296

Other funds holding ZLAB

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Citigroup's ZLAB Position: Q1 2026 in Review

Citigroup reduced its Zai Lab (ZLAB) stake by 81% in Q1 2026, selling an estimated $77.7K and leaving 959 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #4862.

Citigroup first reported a position in ZLAB in Q3 2018 and has held it in 30 quarters since. The position peaked at $17M in Q1 2023. 99 funds tracked by Wall St. Rank hold ZLAB as of Q1 2026.

  • Citigroup held 959 shares of Zai Lab worth $18K as of Q1 2026.
  • Citigroup sold 4,192 Zai Lab shares in Q1 2026, an estimated $77.7K.
  • Zai Lab made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4862 holding.
  • Citigroup first reported a position in Zai Lab in Q3 2018 and has held it in 30 quarters since.
  • Citigroup's Zai Lab position peaked at $17M in Q1 2023.
  • 99 funds tracked by Wall St. Rank held Zai Lab as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.